Acute Erythroblastic Leukemia

Search Trials
A Study to Evaluate the Efficacy and Safety of Maralixibat in Subjects With Progressive Familial Intrahepatic Cholestasis (MARCH-PFIC)
Status:
Recruiting
Last Changed:
Aug 7, 2019
First Changed:
Apr 5, 2019
Disease(s):
Progressive Familial Intrahepatic Cholestasis (PFIC)
Intervention(s):
MaralixibatPlacebo
A Placebo-controlled Study of Maralixibat (SHP625) in Pediatric Subjects With Progressive Familial Intrahepatic Cholestasis (PFIC)
Status:
Withdrawn
Last Changed:
Mar 18, 2019
First Changed:
Nov 27, 2017
Disease(s):
Progressive Familial Intrahepatic Cholestasis (PFIC)
Intervention(s):
MaralixibatPlacebo
Study of Panobinostat Monotherapy in Women With v-ERB-B2 Avian Erythroblastic Leukemia Viral Oncogene Homolog 2 (HER2) Positive Locally Recurrent or Metastatic Breast Cancer
Status:
Terminated
Last Changed:
Nov 24, 2015
First Changed:
Oct 22, 2008
Disease(s):
Breast Cancer
Intervention(s):
Panobinostat - LBH589Panobinostat - LBH589
Molecular Characterization of Acute Erythroid Leukemia (M6-AML) Using Targeted Next-generation Sequencing
Status:
Completed
Last Changed:
Aug 10, 2016
First Changed:
Aug 10, 2016
Disease(s):
Acute Myeloid Leukemia
Intervention(s):
DNA sequencing
Cyclophosphamide for Prevention of Graft-Versus-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation in Patients With Hematological Malignancies
Status:
Completed
Last Changed:
May 19, 2017
First Changed:
Sep 2, 2011
Disease(s):
Accelerated Phase Chronic Myelogenous Leukemia
Intervention(s):
cyclophosphamidecyclosporineperipheral blood stem cell transplantationtotal-body irradiationfludarabine phosphatebusulfanallogeneic hematopoietic stem cell transplantation

Connect. Empower. Inspire.